← Research library

Dalargin and oxidative stress in severe combined trauma: a prospective clinical study

Comparison in people · 2023

What was studied
104 severe combined-trauma patients
Main finding
Among 104 patients (38 Dalargin, 66 controls), the authors reported lower oxidative-stress markers and fewer ARDS/acute kidney injury events. Mortality and infectious complications were comparable; antioxidant activity remained below normal. Hospitalization was shorter among survivors receiving Dalargin.

Mortality · 8/38 (21.1%) versus 17/66 (25.8%) · p=0.6412; nonsignificant

Reported findings and study design

Reported findings

ARDS and kidney injury were less frequent; mortality, infection and overall ICU stay did not differ significantly.

104 trauma patients: 38 Dalargin, 66 controls; allocation safeguards unverified.

Population or model 104 severe combined-trauma patients

Results · Original publisher HTML, selected results and Table 2
MeasureResultComparison, timing and statistics
Mortality8/38 (21.1%) versus 17/66 (25.8%)p=0.6412; nonsignificant
ARDS2/38 (5.3%) versus 14/66 (21.2%)p=0.0457
Acute kidney injury1/38 (2.6%) versus 13/66 (19.7%)p=0.0286
Overall ICU stay12.5 [6.0–34.5] versus 15.0 [5.0–34.0] daysMedian [IQR]; narrative prints 36.5 for the first upper quartile · p=0.8635; nonsignificant
ICU stay among survivors29.0 [12.0–36.0] versus 36.5 [21.8–54.0] daysSurvivor subset; selection may bias comparison · p=0.0015
Infection and antioxidant activityInfections comparable; antioxidant activity remained below normal

Dalargin versus standard care throughout. Unequal groups and unverified assignment prevent causal inference. No survival benefit established.

Source for these results ↗ · Reviewed 2026-11-06

Study limitations and source details

Study limitations

  • Unequal groups; randomized allocation and blinding not established in this appraisal.
  • Biomarker changes do not prove improved survival; survivor-only length of stay requires caution.

Source details

Original publisher HTML, selected clinical outcomes and Table 2 checked. Overall and survivor-only ICU stay distinguished; narrative/table upper-quartile discrepancy retained.

Selected text reviewed

Sources checked

Citation

Human comparative studyFull text available

V. V. Antonova, A. K. Evseev, I. V. Goroncharovskaya, A. Yu. Ryzhkov, O. A. Grebenchikov, A. K. Shabanov. Dalargin and oxidative stress in severe combined trauma: a prospective clinical study Annals of Critical Care. 2023;(4):185–196

Study source ↗ · DOI 10.21320/1818-474X-2023-4-185-196 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards